Cleared Traditional

K941505 - VENTANNA ANTI-CD3 PRIMARY ANTIBODY (FDA 510(k) Clearance)

May 1996
Decision
793d
Days
Class 2
Risk

K941505 is an FDA 510(k) clearance for the VENTANNA ANTI-CD3 PRIMARY ANTIBODY. This device is classified as a Lambda, Antigen, Antiserum, Control (Class II - Special Controls, product code DEH).

Submitted by Ventana Medical Systems, Inc. (Tucson, US). The FDA issued a Cleared decision on May 30, 1996, 793 days after receiving the submission on March 29, 1994.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5550.

Submission Details

510(k) Number K941505 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 29, 1994
Decision Date May 30, 1996
Days to Decision 793 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code DEH — Lambda, Antigen, Antiserum, Control
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5550